0
Five Prime Therapeutics Inc Banner Image

Five Prime Therapeutics Inc

  • Ticker FPRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Five Prime Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ib clinical trials for the treatment of rheumatoid arthritis; and in pre-INDMore stage for pigmented villonodular synovitis and multiple cancers in combination with nivolumab.
Five Prime Therapeutics Inc

Most Recent Responsibility Report

MOST RECENT

Five Prime Therapeutics Inc does not currently have any reports on ResponsibilityReports.com. Click the button below to be notified when financial info becomes available.

Request Information
Our service enables potential investors to review the most recent and archived Five Prime Therapeutics Inc Sustainability Report, Five Prime Therapeutics Inc Corporate Social Responsibility Report, Five Prime Therapeutics Inc CSR Report, Five Prime Therapeutics Inc Corporate Responsibility, Five Prime Therapeutics Inc CR Report, Five Prime Therapeutics Inc Citizenship Report, Five Prime Therapeutics Inc ESG Report, and Five Prime Therapeutics Inc Environmental Report online.